Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 19;11:22586. doi: 10.1038/s41598-021-01851-w

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

(a) Different lymphoma subtypes achieved a comparable long-term outcome (5-year PFS for FL 68.8% vs. MZL 79.4%, p = 0.427). (b) Total radiation dose of > 36.0 Gy had no prognostic influence to PFS (5-year PFS 65.5% vs. 72.1% for > 36.0 Gy vs ≤ 36.0 Gy, p = 0.425). (c) Extranodal involvement was not associated with inferior PFS (5-year PFS 76.0% vs. 69.6% for extranodal and nodal involvement, p = 0.541). (d) Patients who were younger than or equal to 60 y/o had significantly improved PFS compared to patients who were older than 60 y/o (5-year PFS 81.9% and 65.1%, p = 0.021).